About David Gill
Form D filings for Morphoceuticals in 2023 list David Gill as executive officer.
David Gill first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Gill in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Gill works with at each company, as listed on that company's latest Form D.
Morphoceuticals, Inc. · Form D, Jan 23, 2023
AP
Alexander Pickett
Director
ML
Michael Levin
Promoter
DK
David Kaplan
Promoter
AK
Amy Kruse
Director
MH
Michael Hufford
Interim Chief Executive Officer and director
RH
Rosemarie Hunziker
Director